Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Erin Luea"'
Autor:
Mayanka Awasthi, Anthony Macaluso, Scott J. Goebel, Erin Luea, Ryan S. Noyce, Farooq Nasar, Bruce Daugherty, Sina Bavari, Seth Lederman
Publikováno v:
Viruses, Vol 15, Iss 10, p 2131 (2023)
TNX-1800 is a preclinical stage synthetic-derived live attenuated chimeric horsepox virus vaccine engineered to express the SARS-CoV-2 spike (S) gene. The objectives of this study were to assess the safety, tolerability, and immunogenicity of TNX-180
Externí odkaz:
https://doaj.org/article/2706dafabb4a422184b66f17fcd06e82
Autor:
Awasthi, Mayanka1 (AUTHOR) mayanka.awasthi@tonixpharma.com, Macaluso, Anthony1 (AUTHOR) scott.goebel@tonixpharma.com, Goebel, Scott J.1 (AUTHOR) farooq.nasar@tonixpharma.com, Luea, Erin2 (AUTHOR) eluea@southernresearch.org, Noyce, Ryan S.3 (AUTHOR) noyce@ualberta.ca, Nasar, Farooq1 (AUTHOR) sina.bavari@tonixpharma.com, Daugherty, Bruce4 (AUTHOR) bruce.daugherty@tonixpharma.com, Bavari, Sina1 (AUTHOR), Lederman, Seth5 (AUTHOR) seth.lederman@tonixpharma.com
Publikováno v:
Viruses (1999-4915). Oct2023, Vol. 15 Issue 10, p2131. 7p.